Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Drug-induced pemphigoid is an autoimmune blistering condition that can develop as a reaction to certain medications. When specific drugs trigger this response, the immune system begins producing antibodies that attack proteins in the skin, leading to the characteristic blistering symptoms.
This test detects BP230 antibodies in the blood, which are produced when certain medications trigger an autoimmune response similar to bullous pemphigoid. The presence of these antibodies helps confirm the diagnosis and distinguish drug-induced pemphigoid from other blistering conditions. The condition typically resolves once the triggering medication is discontinued.
While the diagnosis of drug-induced pemphigoid involves clinical examination and consideration of medication history, blood tests play a crucial role in confirming the autoimmune nature of the condition. These tests can detect specific antibodies that the body produces in response to certain medications.
A positive BP230 antibody test indicates that your immune system has developed an autoimmune response, likely triggered by a medication you've been taking. This information helps healthcare providers confirm the diagnosis and develop an appropriate treatment plan, which typically involves discontinuing the causative drug.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment. If you suspect a medication is causing skin blistering, do not stop taking prescribed medications without first consulting your healthcare provider.